UK’s GSK to acquire U.S. drugmaker Nuvalent for $10.6 billion as pharma giants race to expand pipelines
The deal comes at a time of biotech dealmaking frenzy, driven by looming patent cliffs, newly buoyant public markets and drugmakers’ race to bolster pipelines.
Trump says Iran deal could be reached in ‘two or three days’ and Strait of Hormuz will reopen ‘immediately’
Speaking to reporters after attending the NBA Finals in New York, Trump said the two parties are in the final stages of a “very, very good deal”.
The space race is coming for pharma: Why drug development is heading to lower Earth orbit
Companies see a commercial opportunity in creating new ways to administer drugs to patients – in space.
Iraq and UAE race to establish alternative oil pipelines as exports through Hormuz dry up
Last week, the Iraqi cabinet approved plans to accelerate crude exports through the Kurdistan-Turkey pipeline network.
BlackRock says ‘mega forces’ are changing investing. Here’s what they say to do
Investors may need to rethink the most basic principles of portfolio management as AI changes the rules, according to BlackRock.
China trade defies Iran war drag as exports, imports beat estimates in May
China’s economy has shown signs of faltering following a strong first-quarter.
Trump booed at Madison Square Garden before Knicks-Spurs NBA finals game
Trump’s decision to attend Game 3 of the NBA Final was controversial for Knicks fans, some of whom feared he would jinx what has been an epic playoff run.
Pentagon expands list of China military-linked firms to include Alibaba, Baidu in fresh blow to diplomatic thaw
The Pentagon briefly posted a similar expanded list in February, then withdrew it without explanation before Trump’s China trip.
OpenAI confidentially files for IPO, prepping Wall Street for mega AI debut
OpenAI’s confidential filing lands days before SpaceX is set to go public and a week after Anthropic announced its confidential disclosure with the SEC.
Bernstein says the future of tech is quantum. These two stocks have the most upside
While it is too early to identify the ultimate winners in quantum computing, two stocks already offer more attractive risk-reward ratios, Wall Street banks said.